About Dycine Pharma
Dycine Pharma was a Healthcare company based in Agra (India) founded in 2010 by Piyush Singh. Dycine Pharma is an emerging group focused on developing and marketing a range of healthcare products. It operates on a B2B model. The company has 248 employees. Its Indian entity Dycine Pharmaceuticals Limited reported revenue of ₹28.83 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Healthcare Products and Product Development.
Company details
Dycine Pharma, founded in 2010 in Agra, India, focuses on providing healthcare solutions, producing pharmaceutical products, healthcare products, and developing products. Dycine Pharma is an emerging group focused on developing and marketing a range of healthcare products. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Agra, India
- Employees 248
- Founders Piyush Singh
- SectorsHealthcare
- Website dycinepharma.com
- Social X
- Legal Name Dycine Pharmaceuticals Limited
- Date of Incorporation 30 Jul, 2010
- Jurisdiction Noida, Uttar Pradesh, India
- Annual Revenue₹28.83 Cr
FY 2025 · +6% YoY
- Net Profit₹65.4 Lakh
FY 2025 · 2% margin
- EBITDA₹5.35 Cr
FY 2025 · 19% margin
- Employee Count248
Associated legal entities of Dycine Pharma
Dycine Pharma operates through Dycine Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Dycine Pharmaceuticals Limited CIN U74992UP2010PLC041545 | Active | 30 Jul 2010 | Noida, Uttar Pradesh | ₹28.8 Cr | 248 | 7 | View details |
Board of directors of Dycine Pharmaceuticals Limited (Dycine Pharma)
Dycine Pharmaceuticals Limited is the primary company behind Dycine Pharma. The board of Dycine Pharmaceuticals Limited currently have 5 directors; the longest-serving is Rupesh Kumar Gupta, appointed in 2010.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rupesh Kumar Gupta DIN 03119045 | Director | 30 Jul 2010 | 16 yrs 2 mo | Dycine Pharmaceuticals Limited |
| Alok Kumar Singh DIN 03119132 | Director | 30 Jul 2010 | 16 yrs 2 mo | Dycine Pharmaceuticals Limited |
| Piyush Kumar Singh DIN 03152890 | Director | 30 Jul 2010 | 16 yrs 2 mo | Dycine Pharmaceuticals Limited |
| Sai Uttam Bahirat Patil DIN 06716471 | Director | 25 Sep 2024 | 2 yrs | Dycine Pharmaceuticals Limited |
| Abhishek Agrawal DIN 08053590 | Director | 25 Sep 2024 | 2 yrs | Dycine Pharmaceuticals Limited |
People of Dycine Pharma
1 people are tracked at Dycine Pharma (1 in leadership); the tracked headcount is 248.
| Name | Role | Group |
|---|---|---|
| Founder, Director | Leadership |
Complete people profiles for Dycine Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Dycine Pharma
Figures of Dycine Pharmaceuticals Limited, the primary company behind Dycine Pharma, for FY 2025. Revenue was ₹28.83 Cr (+6% year on year). Net profit was ₹65.4 Lakh (2% margin). EBITDA was ₹5.35 Cr (19% margin). Revenue has grown at a compounded annual rate of +5% over three years and -2% over five years.
- ₹28.83 CrRevenue · FY 2025 · +6% YoY
- ₹65.4 LakhNet profit · 2% margin
- ₹5.35 CrEBITDA · 19% margin
- ₹26.48 CrPaid-up capital
- 248Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Dycine Pharmaceuticals Limited are on its company page.
Detailed financial statements for Dycine Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Dycine Pharma
Dycine Pharma was founded in 2010.
Dycine Pharma is headquartered in Agra, India. It is registered at Agra, Uttar Pradesh, India.
Dycine Pharma has 248 employees.
The primary company behind Dycine Pharma, Dycine Pharmaceuticals Limited, reported revenue of ₹28.83 Cr for FY 2025, up 6% year on year.
Dycine Pharma, founded in 2010 in Agra, India, focuses on providing healthcare solutions, producing pharmaceutical products, healthcare products, and developing products. Dycine Pharma is an emerging group focused on developing and marketing a range of healthcare products. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Dycine Pharma operates through Dycine Pharmaceuticals Limited.
The legal entities of Dycine Pharma currently have 6 directors, including Rupesh Kumar Gupta, Alok Kumar Singh, Sai Uttam Bahirat Patil and others.